Folate metabolism genes, dietary folate and response to antidepressant medications in late-life depression

International Journal of Geriatric Psychiatry

Volumn 28, Issue 9, 2013, Pages 925-932

  Jamerson, Brenda D ^a,b,c   Payne, Martha E ^b   Garrett, Melanie E ^b   Ashley Koch, Allison E ^b   Speer, Marcy C ^b   Steffens, David C ^b  

^a CAMPBELL UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

antidepressants; depression; depressive disorder genetics; folate; late life depression; single nucleotide polymorphisms

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; METHIONINE SYNTHASE REDUCTASE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; FEMALE; FOLATE METABOLISM; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENOTYPE; HUMAN; LATE LIFE DEPRESSION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NUTRITIONAL ASSESSMENT; ONSET AGE; RACE; REMISSION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ANTIDEPRESSANTS; DEPRESSION; DEPRESSIVE DISORDER/GENETICS; FOLATE; LATE-LIFE DEPRESSION; SINGLE NUCLEOTIDE POLYMORPHISMS;

AGE OF ONSET; AGED; ANTIDEPRESSIVE AGENTS; CYSTATHIONINE BETA-SYNTHASE; DEPRESSIVE DISORDER; DIET; FEMALE; FERREDOXIN-NADP REDUCTASE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLYCINE HYDROXYMETHYLTRANSFERASE; HUMANS; LOGISTIC MODELS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; SEROTONIN UPTAKE INHIBITORS;

EID: 84881372143     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.3899     Document Type: Article

References (38)

1. Abecasis GR, Cookson WO,. 2000. GOLD-graphical overview of linkage disequilibrium. Bioinformatics 16: 182-3.
2. Alpert M, Silva R, Pouget E,. 2003. Prediction of treatment response in geriatric depression from baseline folate level: interaction with an SSRI or a tricyclic antidepressant. J Clin Psychopharm 23 (3): 309-313.
3. Arinami T, Yamada N, Yamakawa-Kobayashi K, Hamaguchi H, Toru M,. 1997. Methylenetetrahydrofolate reductase variant and schizophrenia/depression. Am J Med Genet 74: 526-528.
4. 12, homocysteine, and the MTHFR 677C→T polymorphism in anxiety and depression. Arch Gen Psychiatry 60: 618-626.
5. Blazer D,. 1989. Depression in the elderly. N Engl J Med 320: 164-6.
6. Boyles AL, Billups AV, Deak MC, et al,. 2006, Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. Environ Health Perspect 114: 1547-1552.
7. Coppen A, Bailey J,. 2000. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomized, placebo-controlled trial. J of Affective Disorders 60: 121-130.
8. Fava M, Borus JS, Alpert JE, et al,. 1997. Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry 154 (3): 426-428.
9. Gaysina D, Cohen S, Craddock N, et al,. 2008. No association with the 5,10-Methylenetetrahydrofolate reductase gene and major depressive disorder: results of the depression case control (DeCC) study and a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 147B: 699-706.
10. Gilbody S, Lightfoot T, Sheldon T,. 2007a. Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol Community Health 61: 631.
11. Gilbody S, Lewis S, Lightfoot T,. 2007b. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol 165: 1-13.
12. Hawley CJ, Gale TM, Sivakumaran T,. 2002. Defining remission by cutoff score on the MADRS: selecting the optimal value. J Affect Disord 2: 177-184.
13. Iso H, Moriyama Y, Yoshino K, et al,. 2003. Validity of the self-administered food frequency questionnaire used in the 5-year follow-up survey for the JPHC Study to assess folate, vitamin B6 and B12 intake: comparison with dietary records and blood level. J Epidemiol 13 (1 Suppl): S98-101.
14. Kamphuis MH, Geerlings MI, Grobbee DE, Kromhout D,. 2008. Dietary intake of B(6-9-12) vitamins, serum homocysteine levels and their association with depressive symptoms: the Zutphen Elderly Study. Eur J Clin Nutr 62 (8): 939-45.
15. Kim JM, Stewart R, Kim SW, et al,. 2008. Predictive value of folate, vitamin B12 and homocysteine levels in late-life depression. Br J Psychiatry 192: 268-74.
16. Lancot KL, Rapoport MH, Chan F, et al,. 2010. Genetic predictors of response to treatment with citalopram in depression secondary to traumatic brain injury. Brain Inj 24 (7-8): 959-969.
17. Lewis SJ, Lawlor DA, Smith GD, et al,. 2006. The thermolabile variant of MTHFR is associated with depression in the British women's heart and health study and a meta-analysis. Mol Psychiatry 11: 352-360.
18. Li J, Ji L,. 2005. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95: 221-227.
19. Lievers K, Boers G, Verhoef P, et al,. 2001. A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine and cardiovascular risk. J Mol Med 79: 522-528.
20. Morris MS, Fava M, Jacques PF, Selhub J, Rosenberg IH,. 2003. Depression and folate status in the US population. Psychother Psychosom 72 (2): 80-87.
21. Morrison K, Papapetriou C, Hol FA,. 1998. Susceptibility to spina bifida; an association study of five candidate genes. Ann Hum Genet 62 (pt 5): 379-396.
22. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. 1998. National Academy Press: Washington, DC.
23. Olteanu H, Banerjee R,. 2001. Human methionine synthase reductase, a soluble P-450 reductase-like dual flavoprotein, is sufficient for NADPH-dependent methionine synthase activation. J Biol Chem 276 (38): 35558.
24. Papakostas GI, Petersen T, Mischoulon D, et al,. 2004. Serum folate, vitamin B12, and homocysteine in major depressive disorder, part 1: predictors of clinical response in fluoxetine-resistant depression. J Clin Psychiatry 65: 1090-1095.
25. Papakostas GI, Petersen T, Lebowitz BD, et al,. 2005. The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine. Int J Neuropsychopharmacol 8: 523-528.
26. Paul TP, McDonnell AP, Kelly CB,. 2004. Folic acid: neurochemistry, metabolism and relationship to depression. Human Psychopharmacol Clin Exp 19: 477-488.
27. Payne ME, Hybels CF, Bales CW, Steffens DC,. 2006. Vascular nutritional correlates of late-life depression. Am J Geriatr Psychiatry 14: 787-795.
28. Payne ME, Jamerson BD, Potocky CF, et al,. 2009. Natural food folate and late-life epression. J Nutr Elder 28 (4): 348-358.
29. Reif A, Pfuhlmann B, Lesch KP,. Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Sep; 29 (7): 1162-8.
30. Signorello LB, Buchowski MS, Cai Q, et al,. 2010. Biochemical validation of food frequency questionnaire-estimated carotenoid, alpha-tocopherol, and folate intakes among African Americans and non-Hispanic Whites in the Southern Community Cohort Study. Am J Epidemiol 171 (4): 488-497.
31. Skarupski KA, Tangney C, Li H, et al,. 2010. Longitudinal association of vitamin B-6, folate, and vitamin B-12 with depressive symptoms among older adults over time. Am J Clin Nutr 92 (2): 330-5. PMCID: 2904034.
32. Steffens DC, McQuoid DR, Krishnan KR,. 2002. The Duke Somatic Treatment Algorithm for Geriatric Depression (STAGED) approach. Psychopharmacol Bull 36: 58-68.
33. Trivedi M, Rush JA, Wisniewski S,. 2006. Evaluation of outcomes with citalopram for depression using measurement based care in STAR*D: implications for clinical practice. Am J Psychiatry 163: 28-40.
34. Unutzer J, Katon W, Callahan CM, et al,. 2002. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA 288: 2836-2845.
35. Vailas LI, Nitzke SA,. 1995. Screening for risk of malnutrition in Wisconsin's elderly. Wis Med J 94: 495-9.
36. Zaykin D, Zhivotovsky L, Weir BS,. 1995. Exact tests for association between alleles at arbitrary numbers of loci. Genetica 96: 169-178.
37. Zeng W, Liu L, Tong Y, et al,. 2011. A66G and C524T polymorphisms of the methionine synthase reductase gene are associated with congenital heart defects in the Chinese Han population. Genet Mot Res 10 (4): 2597-2605.
38. Zhu H, Wicker NJ, Shaw GM, et al,. 2003. Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mol Genet Metab 78: 216-221.